Skip to main content

Table 1 Demographic information on MSA and control cases

From: Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity

Brain ID

Age

Gender

PMI (hours)

Disease duration (years)

MSA

 MSA1

61

Male

21

4

 MSA2

82

Male

8

7

 MSA3

74

Male

16

10

 MSA4

67

Male

11

8

 Mean

71 ± 7.8

 

14 ± 4.9

7.3 ± 2.2

Control

 Con1

69

Male

13.5

N/A

 Con2

85

Male

9

N/A

 Con3

65

Male

14.5

N/A

 Con4

88

Male

9

N/A

 Mean

76.8 ± 9.9

 

11.5 ± 2.5

 
  1. PMI postmortem interval. There was no statistically significant difference in age and PMI between MSA and controls. Statistical test: Student’s t-test